AngioDynamics (NASDAQ:ANGO) and Alpha Tau Medical (NASDAQ:DRTS) Head to Head Comparison

AngioDynamics (NASDAQ:ANGO) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk and profitability.

Insider & Institutional Ownership

89.4% of AngioDynamics shares are held by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are held by institutional investors. 5.1% of AngioDynamics shares are held by insiders. Comparatively, 39.5% of Alpha Tau Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for AngioDynamics and Alpha Tau Medical, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AngioDynamics	0	0	3	0	3.00
Alpha Tau Medical	0	0	4	0	3.00

AngioDynamics presently has a consensus price target of $15.00, suggesting a potential upside of 155.54%. Alpha Tau Medical has a consensus price target of $12.00, suggesting a potential upside of 306.78%. Given Alpha Tau Medical’s higher possible upside, analysts clearly believe Alpha Tau Medical is more favorable than AngioDynamics.

Profitability

This table compares AngioDynamics and Alpha Tau Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
AngioDynamics	-4.28%	-1.78%	-1.38%
Alpha Tau Medical	N/A	-31.86%	-26.42%

Earnings and Valuation

This table compares AngioDynamics and Alpha Tau Medical’s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AngioDynamics	$338.75 million	0.69	-$52.44 million	($0.35)	-16.77
Alpha Tau Medical	N/A	N/A	-$29.16 million	($0.42)	-7.02

Alpha Tau Medical has lower revenue, but higher earnings than AngioDynamics. AngioDynamics is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

AngioDynamics has a beta of 0.66, suggesting that its stock price is 34% less volatile than the S&P 500. Comparatively, Alpha Tau Medical has a beta of 0.7, suggesting that its stock price is 30% less volatile than the S&P 500.

Summary

Alpha Tau Medical beats AngioDynamics on 6 of the 11 factors compared between the two stocks.

About AngioDynamics

AngioDynamics, Inc. provides invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology in the United States and internationally. It offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium for treatment of peripheral arterial disease. The company's thrombus management portfolio includes AlphaVac system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac circuit is indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. In addition, it offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. The company also provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

About Alpha Tau Medical

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.